TowerBrook Capital Partners - Private Equity Firm Profile | CT Acquisitions Directory - CT Acquisitions

Firm at a glance

TowerBrook Capital Partners is a platform private equity firm founded in 2000 and headquartered in London, UK, per its own website [S1]. The firm maintains offices in both London and New York and reports approximately $30 billion in assets under management as of January 2025 [S1].

What they buy

Based on publicly disclosed portfolio holdings, TowerBrook appears to concentrate investments across healthcare, business services, and consumer products and services sectors [S2]. The firm’s portfolio pattern suggests a focus on established platform businesses in these verticals, with recent activity spanning healthcare revenue cycle management, professional services, and consumer-facing brands. The firm has also demonstrated interest in financial services and impact-oriented investments, per recent transaction disclosures [S3][S4].

Portfolio

Healthcare

R1 RCM (platform, acquired 2015) and Compassus (platform, acquired 2019) represent the firm’s healthcare holdings [S2].

Business Services

Bruneau (platform, acquired 2021) and EisnerAmper (platform, acquired 2021) comprise the business services segment [S2].

Consumer Products & Services

The AA (platform, acquired 2021), Azzurri Group (platform, acquired 2020), and De Makes Bros (platform, acquired 2023) are listed as consumer-facing platforms [S2].

Recent activity (last 24 months)

* February 2025: Acquired BRG [S3]
* March 2026: Completed continuation vehicle transaction involving EisnerAmper [S4]
* April 2025: Impact fund acquired waste management company for fifth deal [S5]

How this firm fits a seller

TowerBrook’s portfolio composition suggests the firm targets established businesses with defensible market positions in healthcare, professional services, and consumer sectors. The firm’s transatlantic presence with offices in London and New York may appeal to sellers with cross-border operations or expansion ambitions [S1]. The recent continuation vehicle transaction involving EisnerAmper indicates the firm may offer extended hold periods for portfolio companies, which could suit owner-operators seeking patient capital [S4]. For sellers in healthcare services or business services verticals, TowerBrook’s demonstrated sector experience and multi-billion dollar fund size suggest capacity for meaningful platform investments.

Sources

[S1] https://towerbrook.com (as of 2025-01-15)
[S2] https://towerbrook.com/strategy/ (as of 2025-01-15)
[S3] https://www.consulting.us/news/11484/towerbrook-capital-partners-acquires-brg (as of 2025-02)
[S4] https://insidepublicaccounting.com/2026/03/25/eisneramper-continuation-vehicle-transaction-towerbrook/ (as of 2026-03)
[S5] https://www.newprivatemarkets.com/towerbrook-impact-fund-acquires-waste-management-company-for-fifth-deal/ (as of 2025-04)

Frequently asked questions

Does TowerBrook Capital Partners buy Healthcare businesses?

Yes, healthcare represents a documented investment sector for TowerBrook. The firm’s portfolio includes R1 RCM (acquired 2015) and Compassus (acquired 2019), both healthcare platform investments [S2].

What companies has TowerBrook Capital Partners acquired recently?

Recent acquisitions include BRG in February 2025 and a waste management company in April 2025 [S3][S5]. The firm also completed a continuation vehicle transaction for existing portfolio company EisnerAmper in March 2026 [S4].

Where is TowerBrook Capital Partners based and how big is the firm?

TowerBrook is headquartered in London, UK, with an additional office in New York, NY [S1]. The firm reports approximately $30 billion in assets under management as of January 2025 [S1].

Is TowerBrook Capital Partners still actively acquiring?

Yes, TowerBrook appears to remain active, with multiple transactions completed in 2025 and 2026, including the BRG acquisition in February 2025 and a waste management company acquisition in April 2025 [S3][S5].

This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.